European School of Haematology (ESH)’s Post

🚀 Continuing Your Pharma Education: The Large Intestine – Understanding Its Anatomy and Functions 🦠 In our latest article, we explore the Large Intestine, an essential part of the digestive system. Learn about its anatomy, critical functions like water absorption, and common diseases such as IBS and colorectal cancer. This guide is perfect for newcomers in the pharmaceutical industry looking to expand their knowledge of the digestive system. #LargeIntestine #DigestiveHealth #PharmaEducation #IBS #ColorectalCancer #MedicalKnowledge #NewToPharma #pharmaceuticalindustry #HealthcareProfessionals #MedicalRepresentative #PharmaColleagues #Health #MedicalStudent #HealthTips #Anatomy Read the full article now and stay tuned for more! 👇 https://lnkd.in/dnt5DiqV

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Metabolite and biomarker standards are indispensable tools in clinical and diagnostic testing to ensure test results' accuracy, consistency, and reproducibility. Get a broad range of metabolite and biomarker reference materials for clinical and diagnostic testing, pharmaceutical research, and endocrinology. We’ve got you! #clinicaltesting

Today Asimov announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics. Under the agreement, RevOpsis will integrate the CHO Edge System in the development and commercialisation of its first-in-class fully modular tri-specific biologic, RO-104, for the treatment of retinal vascular diseases including neovascular AMD and diabetic macular oedema. Read the full press release here: https://shorturl.at/XtPNi #Bioprocessing #CellLineDevelopment #Ophthalmology #CHO

Our inaugural dermatomyositis (DM) report is hot off the press, unveiling fascinating insights into this complex condition. Did you know that many DM cases go undiagnosed or misdiagnosed due to overlapping symptoms with other autoimmune conditions? With a focus on optimizing patient care, our study with 50 specialists from each field unveils significant insights: 🔍 Half of DM patients are not optimally managed on current treatments. 📈 High demand for advanced treatment options is evident across specialties. 💡 Market potential for upcoming DM therapies is promising, with key contenders like AstraZeneca's Saphnelo, Pfizer's PF-06823859, CSL's Hizentra, Amgen's daxdilimab, and Priovant Therapeutics brepocitinib on the horizon. #marketresearch #rheumatology #dermatomyositis

Check out a few insights from Spherix Global Insights' inaugural dermatomyositis (DM) service highlighting rheumatologists' and dermatologists' perspectives.